Wang Li is a 48-year-old farmer from Dalian, China. After a two-day
trip to the major provincial hospital, he's heading home to his village
to die. Wang has lung cancer, and even with insurance, his surgery will
cost him 20,000 RMB -- $3,000, which is twice his annual salary. The
surgery would be curative, but it doesn't matter. "I cannot burden my
family," he said.
I am a Chinese-born, American physician who just returned from a
two-month research trip spanning twelve cities and nine provinces in
China, where many of the health care reforms in contention in the U.S.
have already been tried. As Americans contemplate the decisions ahead,
consider China's cautionary tale.
Today's China is one of great disparity. The wealthy minority receives
top-notch care, while the poor majority suffers from little access to
care and no way to pay for it. Stories abound of patients like Wang Li
who sign out of hospitals when they run out of savings, knowing they
will die without treatment.
It wasn't always this way. In the mid-20th century, China had universal
health care with a robust primary care system. Millions of "barefoot doctors" provided basic medical services in villages, and attention to prevention ensured significant gains in life expectancy.
The reforms of the 1980s
changed health care from being a social good to a commodity. Universal
insurance was dismantled, and 900 million people lost coverage
overnight. Health care was decentralized to provincial governments, who
allowed the market to operate with few restrictions.
What's emerged is a fragmented system fraught with inefficiencies and
perverse incentives. In Beijing, if a doctor diagnoses someone with a
common cold and sends the patient home, she gets paid, 4.5 RMB, less
than a dollar. But if she orders tests and administers IV antibiotics,
she gets paid 400RMB, 100 times more.
There are additional ethical concerns. Because local governments have ultimate responsibility for service provision,
poor provinces can afford to pay their doctors little more than manual
workers. Doctors are expected to "top up" their salary through other
means. Some earn up to 5 times their salary through kickbacks from
pharmaceutical companies by prescribing new, expensive medications;
others accept direct bribes from patients ("hong bao") as promise for
better care.
The commoditization of health care has caused direct harm to the
patient-physician relationship. Patients question whether doctors are
acting in their best interest. Threats against doctors occur daily, and doctors have become terrified of the people they serve.
Understandably, the attrition rate among doctors is multiplying. The lack of doctors
is particularly acute in rural areas. With low pay and few
opportunities there, doctors flock to cities, leaving many villages
without any doctor. The high reimbursement for treatments has resulted
in a huge pay differential in favor of specialists, and China has gone
from a model primary care system to having virtually no general practitioners.
To its credit, the Chinese government has recognized the inadequacies of
its health care reform, and is making amends including a nationalized health insurance system and a code of conduct for doctors. For the U.S. in considering similar reforms, China's failures offer three important lessons:
First, health insurance does not equate access or coverage. In China, those with insurance still have to pay 60-70% out of pocket,
leaving many without actual health coverage. Taking "personal
responsibility" for our health may be important, but we should not price
people out of life-saving treatments.
Second, fee-for-service should be abolished in favor of
fee-for-diagnosis, with a specific illness billed a fixed amount
regardless of the tests and procedures performed. Not only does such
"bundled payments" require accurate diagnoses, they reduce cost and the
potential for inefficiency and corruption.
Third, health care regulations need to be national decisions. Given the
variability among states and our mobile health care workforce,
decentralized policies don't make sense and will exacerbate
inequalities.
Market-based innovation can still be encouraged with pilot
projects starting at the state level, but the U.S. needs national
consensus on overriding principles.
This year, America has a once-in-a-generation chance to fix our
broken health care system. As policy-makers discuss implementation of
the Accountable Care Act, they should learn from China's experience and
decide whether they see medical care as a commodity or social provision,
and what are the responsibilities of the government to ensure the
health and well-being of its citizens.
source
Friday, March 15, 2013
Subscribe to:
Post Comments (Atom)


No comments:
Post a Comment